Cozad Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $386K | Hold |
6,363
| – | – | 0.03% | 327 |
|
|
2025
Q4 | $343K | Sell |
6,363
-169
| -3% | -$8.13K | 0.03% | 335 |
|
|
2025
Q3 | $295K | Hold |
6,532
| – | – | 0.02% | 356 |
|
|
2025
Q2 | $302K | Buy |
6,532
+175
| +3% | +$8.59K | 0.03% | 343 |
|
|
2025
Q1 | $388K | Sell |
6,357
-50
| -0.8% | -$2.91K | 0.04% | 294 |
|
|
2024
Q4 | $362K | Buy |
6,407
+435
| +7% | +$24.3K | 0.03% | 302 |
|
|
2024
Q3 | $309K | Sell |
5,972
-116
| -2% | -$5.44K | 0.03% | 329 |
|
|
2024
Q2 | $253K | Sell |
6,088
-970
| -14% | -$43.4K | 0.03% | 342 |
|
|
2024
Q1 | $383K | Sell |
7,058
-855
| -11% | -$43.6K | 0.04% | 285 |
|
|
2023
Q4 | $406K | Sell |
7,913
-1,401
| -15% | -$73.5K | 0.05% | 275 |
|
|
2023
Q3 | $541K | Sell |
9,314
-601
| -6% | -$36.8K | 0.07% | 231 |
|
|
2023
Q2 | $634K | Sell |
9,915
-134
| -1% | -$8.99K | 0.08% | 214 |
|
|
2023
Q1 | $696K | Buy |
10,049
+239
| +2% | +$16.9K | 0.09% | 204 |
|
|
2022
Q4 | $706K | Buy |
9,810
+1,942
| +25% | +$146K | 0.1% | 201 |
|
|
2022
Q3 | $559K | Sell |
7,868
-9
| -0.1% | -$653 | 0.09% | 204 |
|
|
2022
Q2 | $607K | Buy |
7,877
+23
| +0.3% | +$1.75K | 0.09% | 194 |
|
|
2022
Q1 | $574K | Buy |
7,854
+1,450
| +23% | +$97.4K | 0.08% | 215 |
|
|
2021
Q4 | $399K | Sell |
6,404
-116
| -2% | -$6.8K | 0.06% | 247 |
|
|
2021
Q3 | $386K | Sell |
6,520
-650
| -9% | -$42.8K | 0.06% | 243 |
|
|
2021
Q2 | $479K | Sell |
7,170
-625
| -8% | -$40.8K | 0.08% | 216 |
|
|
2021
Q1 | $492K | Sell |
7,795
-763
| -9% | -$47.5K | 0.08% | 212 |
|
|
2020
Q4 | $531K | Sell |
8,558
-1,395
| -14% | -$85.8K | 0.09% | 193 |
|
|
2020
Q3 | $600K | Buy |
9,953
+1
| +0% | +$60 | 0.11% | 181 |
|
|
2020
Q2 | $585K | Sell |
9,952
-182
| -2% | -$10.9K | 0.12% | 178 |
|
|
2020
Q1 | $565K | Sell |
10,134
-200
| -2% | -$12.2K | 0.2% | 121 |
|
|
2019
Q4 | $663K | Buy |
10,334
+3,644
| +54% | +$209K | 0.18% | 127 |
|
|
2019
Q3 | $339K | Sell |
6,690
-5
| -0.1% | -$235 | 0.1% | 177 |
|
|
2019
Q2 | $304K | Sell |
6,695
-540
| -7% | -$25.2K | 0.09% | 188 |
|
|
2019
Q1 | $345K | Sell |
7,235
-485
| -6% | -$24.2K | 0.1% | 176 |
|
|
2018
Q4 | $401K | Sell |
7,720
-6,040
| -44% | -$325K | 0.14% | 151 |
|
|
2018
Q3 | $854K | Sell |
13,760
-224
| -2% | -$13.3K | 0.25% | 109 |
|
|
2018
Q2 | $774K | Buy |
+13,984
| New | +$755K | 0.24% | 108 |
|
Other funds holding BMY
VCM
VPM
Cozad Asset Management's BMY Position: Q1 2026 in Review
Cozad Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,363 shares worth $386K. The position accounts for 0.03% of the portfolio, ranked #327.
Cozad Asset Management first reported a position in BMY in Q2 2018 and has held it in 32 quarters since. The position peaked at $854K in Q3 2018. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Cozad Asset Management held 6,363 shares of Bristol-Myers Squibb worth $386K as of Q1 2026.
- Cozad Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.03% of Cozad Asset Management's portfolio in Q1 2026, its #327 holding.
- Cozad Asset Management first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 32 quarters since.
- Cozad Asset Management's Bristol-Myers Squibb position peaked at $854K in Q3 2018.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.